Deadline: 11th March 2024
The Milner Therapeutics Consortium is excited to announce its fourth call for research proposals, which is now open!
The 2024 Milner Consortium Call has an exciting new focus around pharma-led challenges. Our pharma partners in the Milner Therapeutics Consortium have identified topics for challenges that are a current priority for external collaboration with academics. These projects could provide a better understanding of a disease mechanism or discover and validate new therapeutic targets and can range from reagent sharing and 6-month pilots to 2-year postdoctoral funded collaborations. They are expected to lead to joint publications with the company partners.
This call is open to academics at the University, Babraham and Wellcome Sanger Institutes with an idea for a potential pre-clinical collaborative project that would benefit from industry expertise and know-how. Project proposals that could provide solutions to current challenges in the following areas, and applications from cross-disciplinary teams are encouraged:
Neuroscience – Immunology & Inflammation – New technologies – Infectious Disease – Reproductive Medicine – Oncology – Metabolism and Cardiovascular disease
In-person information session
To learn more, please register to attend the i-person information and Q&A session, taking place on 25th January at 2:15pm in the Lecture Theatre at the Jeffrey Cheah Biomedical Centre.
Contact details:
For full details, to download FAQs and an application form, please visit: https://www.milner.cam.ac.uk/consortiumcall
If you have further questions, or an idea for a new collaborative project in key research focus areas, email the Consortium Manager, Asha Carpenter: aamc2@cam.ac.uk
Posted on 23/01/2024
